Tracking how a new lupus medication works in everyday treatment

INTERSTELLAR is a study that tracks people with lupus who are starting anifrolumab, a newer medication for treating this condition. Researchers will collect information about how the medication works and how patients feel over one year. This is not an interventional trial — instead, doctors are simply observing and documenting how the treatment performs when used in regular clinical practice.

Lupus is a serious autoimmune disease, and while this medication has been tested in controlled clinical trials, researchers want to understand how well it actually works and how safe it is when patients use it in their everyday lives outside of a research lab setting.